ClinicalTrials.govpublic full text
Comparative PK Assessment Study of Casdatifan in Moderate Hepatically Impaired Participants Versus Matched Participants With Normal Hepatic Function
healthy participants, hepatic impairment, casdatifan, ab521, hif-2α, pharmacokinetics, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 811616
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.